GlassScriptPhysician profile
Amy Magnuson
NPI 1558521583
$1,906.17
in general payments reported to CMS, 2019-2025
11 companies · $315 in 2025
The $315 reported for 2025 was more than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $197 · 2020: $68.50 · 2021: $35.50 · 2022: $919 · 2023: $240 · 2024: $132 · 2025: $315.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $687.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $686.52 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Cue Health INC. | $866.50 | 2022 | |
| Lilly USA, LLC | $419.82 | 2022-2025 | Zepbound, Mounjaro, Kisunla |
| Novo Nordisk INC | $333.29 | 2019-2025 | Wegovy, Rybelsus, Ozempic |
| Pfizer INC. | $132.00 | 2019-2025 | |
| Abbott Laboratories | $27.68 | 2023 | Freestyle Libre 3 |
| Janssen Pharmaceuticals, INC | $26.75 | 2019-2020 | |
| Linus Health, INC. | $26.48 | 2023 | |
| Nevro Corp. | $20.19 | 2019 | |
| Aytu Biopharma, INC. | $20.07 | 2019 | |
| Glaxosmithkline, LLC. | $18.67 | 2020 | |
| Cranial Technologies, INC | $14.72 | 2023 | Doc Band |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Amy Magnuson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.